Hepatocellular Carcinoma Clinical Trials in Toronto, Ontario

11 recruitingToronto, Ontario, Canada

Showing 111 of 11 trials

Recruiting
Phase 1

A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

Gastric CancerEndometrial CancerHepatocellular Carcinoma+5 more
Seagen, a wholly owned subsidiary of Pfizer714 enrolled61 locationsNCT05208762
Recruiting
Phase 2

A Trial of Casdozokitug in Combination With Toripalimab Plus Bevacizumab in Participants With Unresectable and/or Locally Advanced or Metastatic Hepatocellular Carcinoma

Hepatocellular Carcinoma
Coherus Oncology, Inc.72 enrolled44 locationsNCT06679985
Recruiting
Phase 3

Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma

Hepatocellular Carcinoma
AstraZeneca1,220 enrolled204 locationsNCT06921785
Recruiting
Phase 2

STRIDE (Durvalumab + Tremelimumab) With Lenvatinib vs STRIDE Alone in Unresectable Hepatocellular Carcinoma

Hepatocellular Carcinoma
Canadian Cancer Trials Group140 enrolled10 locationsNCT06880523
Recruiting
Phase 2

Cabozantinib to Treat Recurrent Liver Cancer Post Transplant

Hepatocellular CarcinomaLiver TransplantRecurrent Cancer
University Health Network, Toronto20 enrolled1 locationNCT04204850
Recruiting
Phase 1

Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations

Solid TumorsMetastatic Hepatocellular CarcinomaAdvanced Solid Tumors+11 more
Tyra Biosciences, Inc100 enrolled16 locationsNCT06915753
Recruiting
Phase 1Phase 2

A Study of Tegavivint (BC2059) in Patients With Advanced Hepatocellular Carcinoma

Advanced Hepatocellular Carcinoma
Iterion Therapeutics178 enrolled8 locationsNCT05797805
Recruiting
Not Applicable

The Dragon PLC Trial (DRAGON-PLC)

CholangiocarcinomaHepatocellular Carcinoma (HCC)Primary Liver Cancer
Maastricht University358 enrolled55 locationsNCT06914648
Recruiting
Phase 1

A Phase 1, First in Human Study of TORL-4-500 in Patients With Advanced Cancer

Hepatocellular CarcinomaAdvanced Solid Tumor
TORL Biotherapeutics, LLC70 enrolled10 locationsNCT06005740
Recruiting
Phase 1Phase 2

Using Radiotherapy and Immunotherapy to Treat Advanced Liver Cancer Before Transplant

Hepatocellular Carcinoma (HCC)Liver Transplant SurgeryMacrovascular Invasion+1 more
University Health Network, Toronto48 enrolled2 locationsNCT06725121
Recruiting
Phase 2

Durvalumab and Tremelimumab in Resectable HCC

Hepatocellular Carcinoma
University Health Network, Toronto28 enrolled3 locationsNCT05440864